Cited by 1,406Advanced Drug Delivery SystemsOcular Infections and TreatmentsNanoparticle-Based Drug Delivery

The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.

Ocular Drug Delivery

Open access

Gaudana, Ripal, Ananthula, Hari Krishna, Parenky, Ashwin, Mitra, Ashim K.·2010·The AAPS Journal

DOI 10.1208/s12248-010-9183-3PMC PMC2895432

Open this paper in CoChat — free account Open PDF

Abstract

Ocular drug delivery has been a major challenge to pharmacologists and drug delivery scientists due to its unique anatomy and physiology. Static barriers (different layers of cornea, sclera, and retina including blood aqueous and blood-retinal barriers), dynamic barriers (choroidal and conjunctival blood flow, lymphatic clearance, and tear dilution), and efflux pumps in conjunction pose a significant challenge for delivery of a drug alone or in a dosage form, especially to the posterior segment. Identification of influx transporters on various ocular tissues and designing a transporter-targeted delivery of a parent drug has gathered momentum in recent years. Parallelly, colloidal dosage forms such as nanoparticles, nanomicelles, liposomes, and microemulsions have been widely explored to overcome various static and dynamic barriers. Novel drug delivery strategies such as bioadhesive gels and fibrin sealant-based approaches were developed to sustain drug levels at the target site. Designing noninvasive sustained drug delivery systems and exploring the feasibility of topical application to deliver drugs to the posterior segment may drastically improve drug delivery in the years to come. Current developments in the field of ophthalmic drug delivery promise a significant improvement in overcoming the challenges posed by various anterior and posterior segment diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1208/s12248-010-9183-3

Cites

256 of 256 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Cyclodextrins and their uses: a review
Del Valle, E. M. M. (2004) · Process Biochemistry · doi:10.1016/s0032-9592(03)00258-9 · Cited by 3,375
Cyclodextrins and their pharmaceutical applications
Loftsson, Þ., & Duchêne, D. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.044 · Cited by 1,766
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D.-M., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,681
Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry.
Tomalia, D. A. (2005) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.01.007 · Cited by 1,115
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye
Prausnitz, M. R., & Noonan, J. S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9802594 · Cited by 630
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S., & Mitra, A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 600
Self-citation
Ciliary neurotrophic factor (CNTF) for human retinal degeneration: Phase I trial of CNTF delivered by encapsulated cell intraocular implants
Sieving, P. A., Caruso, R. C., Tao, W., Coleman, H. R., Thompson, D. J. S., Fullmer, K. R., & Bush, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600236103 · Cited by 591
Topical Ocular Drug Delivery: Recent Developments and Future Challenges
Lee, V. H. L., & Robinson, J. R. (1986) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1986.2.67 · Cited by 504

Show all 256 references

Sorted by citations

Ocular drug delivery systems: An overview
Patel, A. (2013) · World Journal of Pharmacology · doi:10.5497/wjp.v2.i2.47 · Cited by 894
Advances in Biomaterials for Drug Delivery
Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 890
Emerging Targets in Photopharmacology
Lerch, M. M., Hansen, M. J., van Dam, G. M., Szymański, W., & Feringa, B. L. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601931 · Cited by 674
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 622
An overview of clinical and commercial impact of drug delivery systems
Anselmo, A. C., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.053 · Cited by 525
Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies
Mandal, A., Bisht, R., Rupenthal, I. D., & Mitra, A. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.012 · Cited by 481
Self-citation
A comprehensive insight on ocular pharmacokinetics
Agrahari, V., Mandal, A., Agrahari, V., Trinh, H. M., Joseph, M. A., Ray, A., Hadji, H., Mitra, R., Pal, D., & Mitra, A. K. (2016) · Drug Delivery and Translational Research · doi:10.1007/s13346-016-0339-2 · Cited by 465
Self-citation
Ocular drug delivery: present innovations and future challenges
Gote, V., Sikder, S., Sicotte, J., & Pal, D. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.256933 · Cited by 441
Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases
Bachu, R. D., Chowdhury, P., Al-Saedi, Z. H. F., Karla, P. K., & Boddu, S. H. S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010028 · Cited by 425
Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering
Eskandari, S., Guerin, T., Tóth, I., & Stephenson, R. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.013 · Cited by 384
Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations
Varela‐Fernández, R., Díaz-Tomé, V., Luaces-Rodríguez, A., Conde-Penedo, A., García‐Otero, X., Álvarez, A. L., Fernández‐Ferreiro, A., & Otero-Espinar, F. J. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030269 · Cited by 374
Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases
Onugwu, A. L., Nwagwu, C. S., Onugwu, S. O., Echezona, A. C., Agbo, C. P., Ihim, S. A., Emeh, P., Nnamani, P. O., Attama, A. A., & Khutoryanskiy, V. V. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.018 · Cited by 356
Lipid Nanoparticles as Carriers for Bioactive Delivery
Dhiman, N., Awasthi, R., Sharma, B., Kharkwal, H., & Kulkarni, G. T. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.580118 · Cited by 348
Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery
Than, A., Liu, C., Chang, H., Duong, P. K., Cheung, C. M. G., Xu, C., Wang, X., & Chen, P. (2018) · Nature Communications · doi:10.1038/s41467-018-06981-w · Cited by 350
Nanoparticles for drug delivery to the anterior segment of the eye
Janagam, D. R., Wu, L., & Lowe, T. L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.001 · Cited by 343
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma
Zhang, K., Zhang, L., & Weinreb, R. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3745 · Cited by 320
Vascular permeability—the essentials
Claesson, L. (2015) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2015.1064501 · Cited by 318
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
Li, S., Chen, L., & Fu, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01992-2 · Cited by 323
Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine
Zhai, J., Fong, C., Tran, N. L., & Drummond, C. J. (2019) · ACS Nano · doi:10.1021/acsnano.8b07961 · Cited by 281
A review on therapeutic contact lenses for ocular drug delivery
Maulvi, F. A., Soni, T. G., & Shah, D. O. (2016) · Drug Delivery · doi:10.3109/10717544.2016.1138342 · Cited by 271
Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
Rzhevskiy, A. S., Singh, T. R. R., Donnelly, R. F., & Anissimov, Y. G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.048 · Cited by 267
Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives
Gaballa, S. A., Kompella, U. B., Elgarhy, O., Alqahtani, A. M., Pierscionek, B., Alany, R. G., & Abdelkader, H. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00843-z · Cited by 255
Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review
Mura, P., Maestrelli, F., Cirri, M., & Mennini, N. (2022) · Marine Drugs · doi:10.3390/md20050335 · Cited by 279
Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application
Tsai, C.-H., Wang, P., Lin, I., Hu, H., Liu, G., & Tseng, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092830 · Cited by 241
Non-viral gene therapy: Gains and challenges of non-invasive administration methods
Földvári, M., Chen, D.-W., Nafissi, N., Calderon-Nieva, D., Narsineni, L., & Rafiee, A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.012 · Cited by 246
Ocular delivery of macromolecules
Kim, Y. C., Chiang, B., Wu, X., & Prausnitz, M. R. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.043 · Cited by 239
Hydrogel Biomaterials for Application in Ocular Drug Delivery
Lynch, C. R., Kondiah, P. P. D., Choonara, Y. E., du Toit, L. C., Ally, N., & Pillay, V. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00228 · Cited by 234
Overcoming ocular drug delivery barriers through the use of physical forces
Huang, D., Chen, Y.-S., & Rupenthal, I. D. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.008 · Cited by 230
Liposomes for intravitreal drug delivery: A state of the art
Bochot, A., & Fattal, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.019 · Cited by 235
Key advances of carboxymethyl cellulose in tissue engineering & 3D bioprinting applications
Zennifer, A., Senthilvelan, P., Sethuraman, S., & Sundaramurthi, D. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117561 · Cited by 229
Thermosensitive Hydrogels and Advances in Their Application in Disease Therapy
Fan, R., Cheng, Y., Wang, R., Zhang, T., Zhang, H., Li, J., Song, S., & Zheng, A. (2022) · Polymers · doi:10.3390/polym14122379 · Cited by 247
A review on recent drug delivery systems for posterior segment of eye
Nayak, K., & Misra, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.138 · Cited by 234
Principles of pharmacology in the eye
Awwad, S., Mohamed Ahmed, A. H. A., Sharma, G., Heng, J. S., Khaw, P. T., Brocchini, S., & Lockwood, A. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14024 · Cited by 224
Retinal Diseases Associated with Oxidative Stress and the Effects of a Free Radical Scavenger (Edaravone)
Masuda, T., Shimazawa, M., & Hara, H. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9208489 · Cited by 221
A comprehensive review on contact lens for ophthalmic drug delivery
Xu, J., Xue, Y., Hu, G., Lin, T., Gou, J., Yin, T., He, H., Zhang, Y. X., & Tang, X. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.020 · Cited by 214
Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System
Akhter, M. H., Ahmad, I. S., Alshahrani, M. Y., Al-Harbi, A. I., Khalilullah, H., Afzal, O., Altamimi, A. S. A., Ullah, S. N. M. N., Ojha, A., & Karim, S. (2022) · Gels · doi:10.3390/gels8020082 · Cited by 215
Cyclodextrin‐Based Formulations: A Non‐Invasive Platform for Targeted Drug Delivery
Muankaew, C., & Loftsson, Þ. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12917 · Cited by 212
Recent Advances in Ocular Drug Delivery Systems
Kuno, N., & Fujii, S. (2011) · Polymers · doi:10.3390/polym3010193 · Cited by 202
Lifitegrast, a Novel Integrin Antagonist for Treatment of Dry Eye Disease
Perez, V. L., Pflugfelder, S. C., Zhang, S., Shojaei, A., & Haque, R. M. (2016) · The Ocular Surface · doi:10.1016/j.jtos.2016.01.001 · Cited by 202
Applications of Chitosan-Alginate-Based Nanoparticles—An Up-to-Date Review
Niculescu, A.-G., & Grumezescu, A. M. (2022) · Nanomaterials · doi:10.3390/nano12020186 · Cited by 199
Hyaluronic acid in ocular drug delivery
Zhang, X., Wei, D., Xu, Y., & Zhu, Q. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118006 · Cited by 196
Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues
Balguri, S. P., Adelli, G. R., & Majumdar, S. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.015 · Cited by 195
Two-Year Intraocular Delivery of Ciliary Neurotrophic Factor by Encapsulated Cell Technology Implants in Patients with Chronic Retinal Degenerative Diseases
Kauper, K., McGovern, C., Sherman, S., Heatherton, P., Rapoza, R., Stabila, P. F., Dean, B., Lee, A., Borges, S., Bouchard, B., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9970 · Cited by 203
Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents
Souto, E. B., Dias-Ferreira, J., López-Machado, A., Ettcheto, M., Cano, A. C., Camins, A., Espina, M., García, M. L., & Sánchez‐López, E. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11090460 · Cited by 196
Natamycin solid lipid nanoparticles – sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization
Khames, A., Khaleel, M. A., El‐Badawy, M. F., & El‐Nezhawy, A. O. H. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s190502 · Cited by 192
Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments
Zamboulis, A., Nanaki, S. G., Michailidou, G., Koumentakou, I., Lazaridou, M., Ainali, N. M., Xanthopoulou, E., & Bikiaris, D. Ν. (2020) · Polymers · doi:10.3390/polym12071519 · Cited by 197
Novel Strategies for Anterior Segment Ocular Drug Delivery
Cholkar, K., Patel, S. P., Vadlapudi, A. D., & Mitra, A. K. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0200 · Cited by 189
Self-citation
Drug delivery to the anterior segment of the eye: A review of current and future treatment strategies
Mofidfar, M., Abdi, B., Ahadian, S., Mostafavi, E., Desai, T. A., Abbasi, F., Sun, Y., Manche, E. E., Ta, C. N., & Flowers, C. W. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120924 · Cited by 201
Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery
Singh, M. V., Bharadwaj, S., Lee, K. E., & Kang, S. G. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.025 · Cited by 187
Ophthalmic Drug Delivery Systems for Antibiotherapy—A Review
Dubald, M., Bourgeois, S., Andrieu, V., & Fessi, H. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010010 · Cited by 176
Subretinal injection: a review on the novel route of therapeutic delivery for vitreoretinal diseases
Peng, Y., Tang, L., & Zhou, Y. (2017) · Ophthalmic Research · doi:10.1159/000479157 · Cited by 175
Minimally invasive microneedles for ocular drug delivery
Singh, R. R. T., Tekko, I. A., McAvoy, K., McMillan, H. L., Jones, D. S., & Donnelly, R. F. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1218460 · Cited by 176
Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems
Madamsetty, V. S., Mohammadinejad, R., Uzielienė, I., Nabavi, N., Dehshahri, A., García-Couce, J., Tavakol, S., Moghassemi, S., Dadashzadeh, A., Makvandi, P., et al. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00026 · Cited by 192
Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview
Almeida, H., Amaral, M. H., Lobão, P., & Lobo, J. M. S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.796360 · Cited by 172
Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye – Part I – Barriers and determining factors in ocular delivery
Sánchez‐López, E., Espina, M., Doktorovová, S., Souto, E. B., & García, M. L. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.009 · Cited by 172
Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: A push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy
Luo, L., Nguyen, D. D., & Lai, J. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119961 · Cited by 172
Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes
McGuckin, M. B., Wang, J., Ghanma, R., Qin, N., Palma, S. D., Donnelly, R. F., & Paredes, A. J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.012 · Cited by 182
Topical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5‐associated Liposomes
Davis, B. M., Normando, E. M., Guo, L., Turner, L., Nizari, S., O’Shea, P., Moss, S. E., Somavarapu, S., & Cordeiro, M. F. (2014) · Small · doi:10.1002/smll.201303433 · Cited by 165
Eye: anatomy, physiology and barriers to drug delivery
Cholkar, K., Dasari, S. R., Pal, D., & Mitra, A. K. (2013) · Elsevier eBooks · doi:10.1533/9781908818317.1 · Cited by 163
Self-citation
Synthesis and Potential Applications of Lipid Nanoparticles in Medicine
Musielak, E., Feliczak‐Guzik, A., & Nowak, I. (2022) · Materials · doi:10.3390/ma15020682 · Cited by 161
In Situ Gel of Triamcinolone Acetonide-Loaded Solid Lipid Nanoparticles for Improved Topical Ocular Delivery: Tear Kinetics and Ocular Disposition Studies
Tatke, A., Dudhipala, N. R., Janga, K. Y., Balguri, S. P., Avula, B., Jablonski, M. M., & Majumdar, S. (2018) · Nanomaterials · doi:10.3390/nano9010033 · Cited by 160
Development and characterization of nano-fiber patch for the treatment of glaucoma
Gagandeep, Garg, T., Malik, B., Rath, G., & Goyal, A. K. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.11.016 · Cited by 158
A Comprehensive Review on Dry Eye Disease: Diagnosis, Medical Management, Recent Developments, and Future Challenges
Phadatare, S. P., Momin, M. M., Nighojkar, P., Askarkar, S., & Singh, K. K. (2015) · Advances in Pharmaceutics · doi:10.1155/2015/704946 · Cited by 157
Liposomes and nanotechnology in drug development: focus on ocular targets
Honda, M., Asai, Oku, Araki, Tanaka, & Ebihara (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s30725 · Cited by 163
Strategies for Improving Ocular Drug Bioavailability and Corneal Wound Healing with Chitosan-Based Delivery Systems
Irimia, T., Ghica, M. V., Popa, L., Anuța, V., Arsene, A., & Dinu‐Pîrvu, C. (2018) · Polymers · doi:10.3390/polym10111221 · Cited by 157
Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits
Chetoni, P., Burgalassi, S., Monti, D., Tampucci, S., Tullio, V. C., Cuffini, A., Muntoni, E., Spagnolo, R., Zara, G. P., & Cavalli, R. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.006 · Cited by 151
Cyclodextrin-Mediated Enhancement of Riboflavin Solubility and Corneal Permeability
Morrison, P. W. J., Connon, C. J., & Khutoryanskiy, V. V. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005963 · Cited by 153
Recent advances in microneedle-based drug delivery: Special emphasis on its use in paediatric population
Duarah, S., Sharma, M., & Wen, J. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.01.005 · Cited by 155
Intelligent wireless theranostic contact lens for electrical sensing and regulation of intraocular pressure
Yang, C. G., Wu, Q., Liu, J., Mo, J., Li, X., Yang, C., Liu, Z., Yang, J., Jiang, L., Chen, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29860-x · Cited by 162
Sustained drug release by contact lenses for glaucoma treatment—A review
de Carvalho, I. A., Marques, C. S., Oliveira, R., Coelho, P. B., Costa, P. C., & Ferreira, D. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.023 · Cited by 149
Advanced drug delivery and targeting technologies for the ocular diseases
Barar, J., Aghanejad, A., Fathi, M., & Omidi, Y. (2016) · Bioimpacts · doi:10.15171/bi.2016.07 · Cited by 148
Contact Lenses: Promising Devices for Ocular Drug Delivery
Guzmán‐Aránguez, A., Colligris, B., & Pintor, J. J. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0212 · Cited by 147
Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
Drag, S., Dotiwala, F., & Upadhyay, A. K. (2023) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.64.7.39 · Cited by 145
Advancing the stimuli response of polymer-based drug delivery systems for ocular disease treatment
Dung, N. D., & Lai, J. (2020) · Polymer Chemistry · doi:10.1039/d0py00919a · Cited by 149
Polymeric Nanoparticles-Loaded Hydrogels for Biomedical Applications: A Systematic Review on In Vivo Findings
Nunes, D., Andrade, S., Ramalho, M. J., Loureiro, J. A., & Pereira, M. D. C. (2022) · Polymers · doi:10.3390/polym14051010 · Cited by 144
Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate
Tan, G., Yu, S., Pan, H., Li, J., Liu, D., Yuan, K., Yang, X., & Pan, W. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.10.035 · Cited by 143
A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments
Periman, L. M., Mah, F. S., & Karpecki, P. M. (2020) · Clinical ophthalmology · doi:10.2147/opth.s279051 · Cited by 149
Overview of Recent Advances in Nano-Based Ocular Drug Delivery
Liu, L.-C., Chen, Y., & Lu, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015352 · Cited by 152
Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye
Loftsson, Þ., & Stefánsson, E. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.010 · Cited by 139
Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations
Lanier, O. L., Manfre, M. G., Bailey, C., Liu, Z., Sparks, Z., Kulkarni, S., & Chauhan, A. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-01977-0 · Cited by 139
Poloxamer 407/TPGS mixed micelles as promising carriers for cyclosporine ocular delivery
Grimaudo, M. A., Pescina, S., Padula, C., Santi, P., Concheiro, A., Alvarez-Lorenzo, C., & Nicoli, S. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00939 · Cited by 138
Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery
Zhang, P., Liu, X., Hu, W., Bai, Y., & Zhang, L. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.04.115 · Cited by 138
Cellulosic Polymers for Enhancing Drug Bioavailability in Ocular Drug Delivery Systems
Gupta, B., Mishra, V., Gharat, S., Momin, M. M., & Omri, A. (2021) · Pharmaceuticals · doi:10.3390/ph14111201 · Cited by 138
Vitreous humor analysis for the detection of xenobiotics in forensic toxicology: a review
Bévalot, F., Cartiser, N., Bottinelli, C., Fanton, L., & Guitton, J. (2015) · Forensic Toxicology · doi:10.1007/s11419-015-0294-5 · Cited by 141
Target strategies for drug delivery bypassing ocular barriers
Suri, R., Beg, S., & Kohli, K. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101389 · Cited by 134
Nanoemulsion Based Vehicle for Effective Ocular Delivery of Moxifloxacin Using Experimental Design and Pharmacokinetic Study in Rabbits
Shah, J., Nair, A. B., Jacob, S., Patel, R. K., Shah, H., Shehata, T. M., & Morsy, M. A. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11050230 · Cited by 132
Potential chitosan-coated alginate nanoparticles for ocular delivery of daptomycin
Costa, J. R., Silva, N. C., Sarmento, B. F. C. C., & Pintado, M. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2344-7 · Cited by 130
Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo , in vitro and ex vivo studies
Fangueiro, J. F., Calpena, A. C., Clares, B., Andreani, T., Egea, M. A., Veiga, F., García, M. L., Silva, A. M., & Souto, E. B. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.02.039 · Cited by 130
Contact lenses as a platform for ocular drug delivery
Bengani, L. C., Hsu, K.-H., Gause, S., & Chauhan, A. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.821462 · Cited by 129
In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye
Peynshaert, K., Devoldere, J., Smedt, S. C. D., & Remaut, K. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.007 · Cited by 138
Topical delivery of ocular therapeutics: carrier systems and physical methods
de Souza, J. G., Dias, K., Pereira, T. A., Bernardi, D. S., & Lopez, R. F. V. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12132 · Cited by 128
MOF-Based Polymeric Nanocomposite Films as Potential Materials for Drug Delivery Devices in Ocular Therapeutics
Gándara-Loe, J., Souza, B. E., Missyul, A. B., Durango-Giraldo, G., Tan, J., & Silvestre‐Albero, J. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c07517 · Cited by 128
Engineering Smart Targeting Nanovesicles and Their Combination with Hydrogels for Controlled Drug Delivery
Elkhoury, K., Koçak, P., Kang, A., Arab‐Tehrany, E., Ward, J. E., & Shin, S. R. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090849 · Cited by 132
Gold nanoparticles in ophthalmology
Masse, F., Ouellette, M., Lamoureux, G., & Boisselier, É. (2018) · Medicinal Research Reviews · doi:10.1002/med.21509 · Cited by 130
Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery
Gupta, H., Velpandian, T., & Jain, S. (2010) · Journal of drug targeting · doi:10.3109/10611860903508788 · Cited by 127
Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle
Jung, J. H., Chiang, B., Grossniklaus, H. E., & Prausnitz, M. R. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.001 · Cited by 131
Nanotechnology approaches for ocular drug delivery
Kannan, R. M., Xu, Q., & Kambhampati, S. P. (2013) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.106384 · Cited by 125
Corneal Cross-linking: Intrastromal Riboflavin Concentration in Iontophoresis-Assisted Imbibition Versus Traditional and Transepithelial Techniques
Mastropasqua, L., Nubile, M., Calienno, R., Mattei, P. A., Pedrotti, E., Salgari, N., Mastropasqua, R., & Lanzini, M. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.11.018 · Cited by 125
A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine
Lai, J., & Hsieh, A.-C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.085 · Cited by 125
The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies
Herrero‐Vanrell, R., Bravo‐Osuna, I., Andrés‐Guerrero, V., Vicario‐de‐la‐Torre, M., & Molina-Martínez, I. T. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.04.002 · Cited by 130

Authors: Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K.
Affiliations: University of Missouri–Kansas City (US)
Corresponding author: Mitra, Ashim K.
Venue: The AAPS Journal
Publisher: Springer Science and Business Media LLC
Published: 2010-05-01
Volume: 12
Issue: 3
Pages: 348-360
ISSN: 1550-7416 (ISSN-L)
DOI: 10.1208/s12248-010-9183-3
PMC: PMC2895432
OpenAlex: W2018516156
Cited by: 1,406
References: 256
Citations by year: 2026: 114 · 2025: 114 · 2024: 98 · 2023: 118 · 2022: 110 · 2021: 126 · 2020: 116 · 2019: 93 · 2018: 100 · 2017: 96 · 2016: 82 · 2015: 60 · 2014: 54 · 2013: 58 · 2012: 32
FWCI: 4.89
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: The AAPS Journal (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Eye Institute (R01EY009171, R01EY10659-12, R01EY010659, R01-EY09171-14)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords: ocular drug delivery, blood-aqueous barrier, blood-retinal barrier, cornea, sclera, retina, choroidal blood flow, lymphatic clearance, efflux pumps, influx transporters, nanoparticles, nanomicelles, liposomes, microemulsions, bioadhesive gel, fibrin glue, sustained drug release, topical drug delivery, posterior segment, anterior segment
MeSH terms: Administration, Topical, Colloids, Eye, Half-Life, Humans, Iontophoresis, Melanins, Pharmacokinetics, Ultrasonics, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Ocular Drug Delivery

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks